Expression and functional role of ALDH1 in cervical carcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1325-1331

  Rao, Qun Xian ^a   Yao, Ting Ting ^a   Zhang, Bing Zhong ^a   Lin, Rong Chun ^a   Chen, Zhi Liao ^a   Zhou, Hui ^a   Wang, Li Juan ^a   Lu, Huai Wu ^a   Chen, Qin ^a   Di, Na ^a   Lin, Zhong Qiu ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adhehyde dehydrogenase; Cancer stem cells; Cervical cancer; Migration; Proliferation; Tumorigenic

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ISOENZYME; RETINAL DEHYDROGENASE; TUMOR MARKER;

ANIMAL; ARTICLE; CANCER STEM CELL; CARCINOMA; CELL MOTION; CELL PROLIFERATION; ENZYMOLOGY; FEMALE; HELA CELL; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; UTERINE CERVIX TUMOR;

ANIMALS; CARCINOMA; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HELA CELLS; HUMANS; ISOENZYMES; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84873034242     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1325     Document Type: Article

References (35)

1. Charafe-Jauffret E, Ginestier C, Iovino F, et al (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res, 16, 45-55.
2. Corti S, Locatelli F, Papadimitriou D, et al (2006). Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells, 24
3. Croker AK, Goodale D, Chu J, et al (2009). High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med, 13, 2236-52.
4. Friedman GK, Gillespie GY (2011). Cancer stem cells and pediatric solid tumors. Cancers, 3, 298-318.
5. Ghaffari S (2011). Cancer, stem cells and cancer stem cells: old ideas, new developments. F1000 Med Rep, 3, 23.
6. Ginestier C, Wicinski J, Cervera N, et al (2009). Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle, 8, 3297-302.
7. Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ (2011). Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cell Oncol, 34, 3-10.
8. Jiang F, Qiu Q, Khanna A, et al (2009). Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res, 7, 330-8.
9. Kahlert C, Bergmann F, Beck J, et al (2011). Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer, 11, 275.
10. Lapidot T, Sirard C, Vormoor J, et al (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-8.
11. Logan CY, Nusse R (2004). The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol, 20, 781-810.
12. Ma S, Chan KW, Lee TK, et al (2008). Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations, Mol Cancer Res, 6, 1146-53.
13. Moody CA, Laimins LA (2010). Human papillomavirus oncoproteins: pathways to transformation. Nature Rev Cancer, 10, 550-60.
14. Moreb JS, Ucar D, Han S, et al (2012). The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact, 195, 52-60.
15. Moreb JS, Zucali JR, Ostmark B, Benson NA (2007). Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. Cytometry B Clin Cytom, 72, 281-9.
16. Morimoto K, Kim SJ, Tanei T, et al (2009). Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci, 100, 1062-8.
17. Park CH, Bergsagel DE, McCulloch EA (1971). Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst, 46, 411-22.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-11.
19. Rice KL, Izon DJ, Ford J, et al (2008). Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors. Leuk Res, 32, 873-83.
20. Sagar J, Chaib B, Sales K, Winslet M, Seifalian A (2007). Seifalian, Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int, 7, 9.
21. Saini V, Shoemaker RH (2010). Potential for therapeutic targeting of tumor stem cells. Cancer Sci, 101, 16-21.
22. Schnier JB, Kaur G, Kaiser A, et al (1999). Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein. FEBS Lett, 454, 100-4.
23. Scholl SM, Kenter G, Kurzeder C, Beuzeboc P (2011). Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective. ISRN Oncol, 2011, 403098.
24. Sophos NA, Vasiliou V (2003). Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact, 143-144, 5-22.
25. Stanley M (2010). Pathology and epidemiology of HPV infection in females. Gynecol Oncol, 117, S5-10.
26. Storms RW, Green PD, Safford KM, et al (2005). Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood, 106, 95-102.
27. Su Y, Qiu Q, Zhang X, et al (2010). Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev, 19, 327-37.
28. Vasiliou V, Pappa A, Petersen DR (2000). Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact, 129, 1-19.
29. Vogler T, Kriegl L, Horst D, et al (2011). The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. Exp Mol Pathol, 92, 111-7.
30. Wakamatsu Y, Sakamoto N, Oo HZ, et al (2012). Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int, 62, 112-9.
31. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
32. Wang YC, Yo YT, Lee HY, et al (2012). ALDH1-bright epithelial ovarian cancer cells are associated with CD44. Drug resistance, and poor clinical outcome. Am J Pathol, 180, 1159-69.
33. Wang Y, Zhe H, Gao P, et al (2011). Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China. Diseases of the Esophagus; doi: 10.1111/j.1442-2050.2011.01279.x
34. Yao T, Chen Q, Zhang B, Zhou H, Lin Z (2011). The expression of ALDH1 in cervical carcinoma. Med Sci Monit, 17, HY21-26.
35. Yoshida A, Hsu LC, Davé V (1992). Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme, 46, 239-44.